Healthpeak Properties, Inc. (Old)

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US42250P1030
USD
17.18
-0.11 (-0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.15 M

Shareholding (Mar 2025)

FII

24.09%

Held by 328 FIIs

DII

35.7%

Held by 115 DIIs

Promoter

0.06%

How big is Healthpeak Properties, Inc. (Old)?

22-Jun-2025

As of Jun 18, Healthpeak Properties, Inc. (Old) has a market capitalization of $11.90 billion, with net sales of $2.80 billion and a net profit of $305.16 million over the latest four quarters. Shareholder's funds total $8.40 billion, and total assets are reported at $19.94 billion as of Dec'24.

Market Cap: As of Jun 18, Healthpeak Properties, Inc. (Old) has a market capitalization of 11,899.61 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Healthpeak Properties, Inc. (Old) reported net sales of 2,796.78 million and a net profit of 305.16 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the shareholder's funds amount to 8,401.28 million, while total assets are reported at 19,938.26 million.

Read More

What does Healthpeak Properties, Inc. (Old) do?

22-Jun-2025

Healthpeak Properties, Inc. (Old) is a mid-cap real estate investment trust focused on healthcare-related real estate in the U.S., with recent net sales of $703 million and a market cap of approximately $11.9 billion. Key metrics include a P/E ratio of 38.00 and a dividend yield of 5.95%.

Overview:<BR>Healthpeak Properties, Inc. (Old) is a diversified real estate investment trust that invests in real estate serving the healthcare industry in the United States, operating within the Realty industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 703 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 50 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 11,899.61 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 38.00 <BR>Dividend Yield: 5.95% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 3.86% <BR>Price to Book: 1.45<BR><BR>Contact Details:<BR>Address: 5050 SOUTH SYRACUSE STREET, SUITE 800, DENVER CO : 80237 <BR>Tel: ['1 949 4070700', '1 949 4070400'] <BR>Fax: 1 562 7335200 <BR>Website: https://www.healthpeak.com/

Read More

Who are in the management team of Healthpeak Properties, Inc. (Old)?

22-Jun-2025

As of March 2022, the management team of Healthpeak Properties, Inc. includes Mr. Brian Cartwright (Independent Chairman), Mr. Thomas Herzog (CEO), and six independent directors: Ms. Christine Garvey, Mr. R. Kent Griffin, Ms. Sara Grootwassink Lewis, Mr. David Henry, and Ms. Lydia Kennard. This diverse team oversees the company's governance and strategic direction.

As of March 2022, the management team of Healthpeak Properties, Inc. (Old) includes the following individuals:<BR><BR>- Mr. Brian Cartwright, Independent Chairman of the Board<BR>- Mr. Thomas Herzog, Chief Executive Officer and Director<BR>- Ms. Christine Garvey, Independent Director<BR>- Mr. R. Kent Griffin, Independent Director<BR>- Ms. Sara Grootwassink Lewis, Independent Director<BR>- Mr. David Henry, Independent Director<BR>- Ms. Lydia Kennard, Independent Director<BR><BR>This team comprises a mix of executive leadership and independent directors, contributing to the governance and strategic direction of the company.

Read More

Is Healthpeak Properties, Inc. (Old) overvalued or undervalued?

20-Sep-2025

As of February 3, 2025, Healthpeak Properties, Inc. is considered very attractive in valuation despite underperforming the S&P 500, with a P/E ratio of 38 compared to peers and a favorable EV to EBITDA ratio of 7.48, suggesting it may be undervalued at its current price of 18.57.

As of 3 February 2025, the valuation grade for Healthpeak Properties, Inc. (Old) moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company appears undervalued, particularly when considering its P/E ratio of 38, which is notably higher than peers like Gaming & Leisure Properties, Inc. with a P/E of 18.89 and Host Hotels & Resorts, Inc. at 19.10. Additionally, Healthpeak's EV to EBITDA ratio stands at 7.48, which is more favorable compared to Regency Centers Corp. at 28.07, suggesting that Healthpeak may offer better value relative to its earnings potential.<BR><BR>Despite the attractive valuation metrics, Healthpeak has underperformed the S&P 500 in multiple time frames, with a year-to-date return of -8.39% compared to the S&P 500's 12.22%, and a three-year return of -27.80% versus the S&P 500's 70.41%. This underperformance may reflect broader market trends or specific challenges within the company, but the current valuation ratios suggest that it could be an appealing investment opportunity at its current price of 18.57.

Read More

Is Healthpeak Properties, Inc. (Old) technically bullish or bearish?

20-Sep-2025

As of August 22, 2025, Healthpeak Properties, Inc. shows a mildly bearish trend with daily moving averages indicating bearishness, while longer-term performance has underperformed against the S&P 500, with year-to-date and one-year returns of -8.39% and -16.05%, respectively.

As of 22 August 2025, the technical trend for Healthpeak Properties, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish trend, while the weekly MACD and KST show a mildly bullish signal. The Bollinger Bands on a weekly basis are bullish, but the monthly indicators reflect a bearish sentiment. <BR><BR>In terms of performance, the stock has underperformed against the S&P 500 over the longer term, with a year-to-date return of -8.39% compared to the S&P 500's 12.22%, and a one-year return of -16.05% versus 17.14% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • NET PROFIT(Q) At USD 44.84 MM has Fallen at -43.54%
  • ROCE(HY) Lowest at 1.97%
  • INTEREST COVERAGE RATIO(Q) Lowest at 524.76
2

With ROE of 3.86%, it has a very attractive valuation with a 1.47 Price to Book Value

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 12,263 Million (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

5.60%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

2.64%

stock-summary
Price to Book

1.55

Revenue and Profits:
Net Sales:
694 Million
(Quarterly Results - Jun 2025)
Net Profit:
39 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.56%
0%
-4.56%
6 Months
0.47%
0%
0.47%
1 Year
-19.34%
0%
-19.34%
2 Years
-6.98%
0%
-6.98%
3 Years
-34.38%
0%
-34.38%
4 Years
-48.7%
0%
-48.7%
5 Years
-43.84%
0%
-43.84%

Healthpeak Properties, Inc. (Old) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.50%
EBIT Growth (5y)
10.72%
EBIT to Interest (avg)
3.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
334.63%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
7.82%
ROE (avg)
5.49%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
1.47
EV to EBIT
24.38
EV to EBITDA
7.48
EV to Capital Employed
1.48
EV to Sales
4.27
PEG Ratio
32.79
Dividend Yield
5.28%
ROCE (Latest)
6.08%
ROE (Latest)
3.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 143 Schemes (40.14%)

Foreign Institutions

Held by 328 Foreign Institutions (24.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.22% vs 0.70% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -21.57% vs 372.38% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "694.30",
          "val2": "702.90",
          "chgp": "-1.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "393.90",
          "val2": "407.20",
          "chgp": "-3.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.10",
          "val2": "72.70",
          "chgp": "3.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.10",
          "val2": "-1.30",
          "chgp": "-984.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "38.90",
          "val2": "49.60",
          "chgp": "-21.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "184.30%",
          "val2": "197.20%",
          "chgp": "-1.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 23.81% vs 5.81% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -19.97% vs -34.99% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,700.40",
          "val2": "2,181.00",
          "chgp": "23.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,518.40",
          "val2": "1,189.40",
          "chgp": "27.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "280.40",
          "val2": "200.30",
          "chgp": "39.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-145.70",
          "val2": "-17.30",
          "chgp": "-742.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "266.50",
          "val2": "333.00",
          "chgp": "-19.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "170.80%",
          "val2": "201.50%",
          "chgp": "-3.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
694.30
702.90
-1.22%
Operating Profit (PBDIT) excl Other Income
393.90
407.20
-3.27%
Interest
75.10
72.70
3.30%
Exceptional Items
-14.10
-1.30
-984.62%
Consolidate Net Profit
38.90
49.60
-21.57%
Operating Profit Margin (Excl OI)
184.30%
197.20%
-1.29%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.22% vs 0.70% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -21.57% vs 372.38% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,700.40
2,181.00
23.81%
Operating Profit (PBDIT) excl Other Income
1,518.40
1,189.40
27.66%
Interest
280.40
200.30
39.99%
Exceptional Items
-145.70
-17.30
-742.20%
Consolidate Net Profit
266.50
333.00
-19.97%
Operating Profit Margin (Excl OI)
170.80%
201.50%
-3.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 23.81% vs 5.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -19.97% vs -34.99% in Dec 2023

stock-summaryCompany CV
About Healthpeak Properties, Inc. (Old) stock-summary
stock-summary
Healthpeak Properties, Inc. (Old)
Realty
Healthpeak Properties, Inc., formerly HCP, Inc., is a diversified real estate investment trust, which invests in real estate serving the healthcare industry in the United States. The Company acquires, develops, leases, owns and manages healthcare real estate facilities. The Company's segments include senior housing triple-net, senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings include physicians' offices and examination rooms.
Company Coordinates stock-summary
Company Details
5050 SOUTH SYRACUSE STREET, SUITE 800 , DENVER CO : 80237
stock-summary
Tel: 1 949 40707001 949 4070400
stock-summary
Registrar Details